Comparison between Era Constructions FPO and Nectar Lifesciences IPO.
Era Constructions FPO is a Mainboard Bookbuilding IPO proposed to list at BSE while Nectar Lifesciences IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Era Constructions FPO is up to ₹41.04 Cr whereas the issue size of the Nectar Lifesciences IPO is up to ₹92.88 Cr. The final issue price of Era Constructions FPO is ₹72.00 per share and of Nectar Lifesciences IPO is ₹240.00 per share.
| Era Constructions FPO | Nectar Lifesciences IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹200.00 per share | |
| Issue Price (Upper) | ₹240.00 per share | |
| Issue Price (Final) | ₹72.00 per share | ₹240.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 57,00,352 shares | 38,70,000 shares |
| Fresh Issue Size (Amount) | up to ₹41.04 Cr | up to ₹92.88 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 57,00,352 shares | 38,70,000 shares |
| Issue Size Total (Amount) | up to ₹41.04 Cr | up to ₹92.88 Cr |
Era Constructions FPO opens on Jun 24, 2005, while Nectar Lifesciences IPO opens on Jun 22, 2005. The closing date of Era Constructions FPO and Nectar Lifesciences IPO is Jun 29, 2005, and Jun 28, 2005, respectively.
Era Constructions FPO P/E ratio is , as compared to Nectar Lifesciences IPO P/E ratio of .
| Era Constructions FPO | Nectar Lifesciences IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 40.44 | 89.08 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 28.23 | 65.93 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 16.93 | 31.3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Era Constructions FPO Retail Individual Investors (RII) are offered 14,25,000 shares while in Nectar Lifesciences IPO retail investors are offered 14,25,000 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Era Constructions FPO and 19,35,000 shares in Nectar Lifesciences IPO.
| Era Constructions FPO | Nectar Lifesciences IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 0 shares | 19,35,000 shares |
| NII | 14,25,000 shares | 5,80,500 shares |
| RII | 14,25,000 shares | 13,54,500 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 57,00,000 shares | 38,70,000 shares |
Era Constructions FPO subscribed in total, whereas Nectar Lifesciences IPO subscribed .
